MPH Health Care AG is a listed investment company with a strategic focus on investments in the growth segments of the healthcare market around chronic diseases, medical aesthetic treatments and digitalisation in the healthcare sector. In addition, MPH specifically exploits potential in other high-growth and high-profit sectors. It invests for the long term and allows its shareholders to participate in the development of its holdings through an attractive dividend policy.

Stock

ISIN: DE000A289V03 | WKN: A289V0 | Stock exchange symbol: 93M1

Title name: Bearer Shares
Number of shares: 4,281,384
Designated Sponsor: ODDO SEYDLER BANK AG
First trading day: 01.09.2009

Share information

Downloads

You can find our current annual and interim reports here: Reports

| Investor News

  • Equity (net asset value) amounts to EUR 257.9 million, which corresponds to EUR 60.24 per share.
  • Equity ratio decreases slightly to 94.9% (31 December 2024: 95.5%)

| Investor News

  • Net profit (IFRS) increases to EUR 32.0 mn (previous year: EUR 29.5 mn)
  • EBIT increases by 9.1% to EUR 33.0 mn (previous year: EUR 30.2 mn)
  • Equity ratio: increase from 94.2% to 95.5%
  • Equity increases from EUR 251.0 mn to EUR 277.9 mn as of 31 December 2024

| Investor News

MPH Health Care AG announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024.

Contact

MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Deutschland

T. +49 (0) 30 863 21 45 – 60

To the contact form